Rush immunotherapy with multiple aeroallergens is safe in an adult population
Background: The safety of rush subcutaneous immunotherapy (SCIT) to multiple aeroallergens has not been widely studied. The objectives of this retrospective study were to evaluate the incidence of adverse reactions of a rush immunotherapy scheme with five injections at the first day with different a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Stichting NASE
2018-05-01
|
| Series: | Rhinology Online |
| Subjects: | |
| Online Access: | https://www.rhinologyonline.org/Rhinology_online_issues/manuscript_7.pdf |